Aleix Prat
- Specializzazione: Clinical oncologist
- 23 anni di esperienza
- Lingue parlate:English, Spanish
- Consultazioni online: disponibili
- Studio medico: Spain, Barcelona, Hospital Quiron Barcelona
- Head of Medical Oncology, Hospital Clínic of Barcelona Head of Translational Genomics and Targeted Therapeutics Group (IDIBAPS). Head of the Breast Cancer programme at IOB-Quirón Salud
Dr. Aleix Prat is a clinical scientist with expertise in breast cancer research, gene expression, and clinical trials. He earned his MD from the University of Barcelona. He completed his oncology fellowship at Vall d’Hebron Institute of Oncology. Dr. Prat leads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS. He is also President of SOLTI and serves on the Executive Committee of The Breast International Group.
Dr. Prat has published over 160 scientific papers. His work has received 13,479 citations, and he has an H-Index of 51. He is a Tenure-Track Professor at the University of Barcelona. He also directs the Breast Pathology–Senology Master’s degree. His roles highlight his strong academic and clinical contributions to oncology.
Consulto medico online con Aleix Prat
Recensioni dei pazienti
Servizi medici
Com'è andata la tua esperienza?
Formazione accademica
Dr. Prat is a clinical scientist with a longstanding research interest in the clinical application of laboratory findings in breast cancer, with a particular interest in gene expression and the clinical implications of different intrinsic molecular subtypes of breast cancer and also he designs and leads clinical trials of novel drugs and approaches at SOLTI, a Spanish breast cancer cooperative group.
Formation
- MD degree in 2003 from the University of Barcelona.
- medical oncology fellowship in 2008 at Vall d´Hebron Institute of Oncology (VHIO).
- postdoctoral research associate at the Lineberger Comprehensive Cancer Center (University of North Carolina at Chapel Hill, USA) in the Laboratory of Prof. Charles M. Perou, in 2008.
Track
- Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute (IDIBAPS).
- President of the Board of Directors of SOLTI.
- member of the Executive Committee of The Breast International Group (BIG) in 2018.
- co-founder of the spin-off called Reveal Genomics, SL.
- holds three issued patents, which certificates a stable scientific career.
- Head of the Translational Genomics Group at VHIO (2012).
- Hospital Clínic and IDIBAPS (2014).
Publications
Part of more than 160 publications (H-Index Score of 51), with a total of 13.479 citations and 95 communications in international conferences.
Teaching
- Tenure-Track Professor of Barcelona University (UB)
- Director, Breast Pathology – Senology Master´s degree, UB.
Potrebbe interessarti anche
Pagamenti e Benefici
I nostri servizi sono gratuiti
Il pagamento viene effettuato direttamente presso la clinica oppure tramite bonifico sul loro conto bancario ufficiale.
Alcune cliniche possono richiedere un deposito come parte della loro politica.
Paghi comodamente a rate flessibili.
Ricevi premi per raccomandare Bookimed ai tuoi amici.